Northern Financial Advisors Inc

Position in MRK — Merck & Co., Inc.

CIK 1962457 BLOOMFIELD HILLS, MI

Position in MRK

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$1,079,143

+$86,150 QoQ

Shares Held

8,398

+1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#2,053

of 3,768 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Northern Financial Advisors Inc holds $8,250,442 across 7 Drug Manufacturers - General names. MRK ranks #5 (13.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,910	$2,290,911
2	AMGN	Amgen Inc	3,847	$1,393,075
3	JNJ	Johnson & Johnson	4,699	$1,193,405
4	GILD	Gilead Sciences, Inc.	8,647	$1,092,461
5	MRK	Merck & Co., Inc. This page	8,398	$1,079,143
6	ABBV	AbbVie Inc.	3,712	$934,087
7	PFE	Pfizer Inc	11,103	$267,360

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,079,143	8,398	+1.7%	Shares	Sole	2026-07-28
2026-03-31	$992,993	8,255	+76.4%	Shares	Sole	2026-04-28
2025-12-31	$492,722	4,681	-37.0%	Shares	Sole	2026-01-27
2025-09-30	$623,180	7,425	-5.9%	Shares	Sole	2025-11-10
2025-06-30	$624,334	7,887	-8.1%	Shares	Sole	2025-07-23
2025-03-31	$770,679	8,586	-41.2%	Shares	Sole	2025-05-06
2024-12-31	$1,451,711	14,593	-27.2%	Shares	Sole	2025-01-30
2024-09-30	$2,276,083	20,043	-8.5%	Shares	Sole	2024-10-29
2024-06-30	$2,711,715	21,904	+2.2%	Shares	Sole	2024-08-05
2024-03-31	$2,829,008	21,440	+1.6%	Shares	Sole	2024-04-30
2023-12-31	$2,300,976	21,106	+3.9%	Shares	Sole	2024-02-06
2023-09-30	$2,090,399	20,305	+0.0%	Shares	Sole	2023-11-14
2023-06-30	$2,342,532	20,301	-0.1%	Shares	Sole	2023-07-21
2023-03-31	$2,161,100	20,313	-0.0%	Shares	Sole	2023-04-27
2022-12-31	$2,254,504	20,320	—	Shares	Sole	2023-01-30
No filing history on record for this holder in this stock.